We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Time for Investors To Revisit the Pandemic Winners?
A handful of stocks benefited massively during the initial phases of the pandemic. It was a fascinating time to be an investor, and those who targeted the stay-at-home stocks were rewarded handsomely with considerable gains.
In 2022, these once seemingly unstoppable investments have found themselves deep in the red, leaving dents in many portfolios. The Fed's tightening cycle has massively affected many of these high-growth pandemic winners.
Three stocks that gained widespread popularity during the period include Teladoc (TDOC - Free Report) , Zoom Video Communications (ZM - Free Report) , and Peloton Interactive (PTON - Free Report) .
Below is a YTD chart depicting the share performance of all three companies with the S&P 500 blended in as a benchmark.
Image Source: Zacks Investment Research
It raises a valid question, are these one-time massive winners still worth investors’ attention? Let’s take a closer look.
Teladoc
Teladoc Health (TDOC - Free Report) can diagnose and treat most non-emergency conditions such as flu, seasonal allergies, upper respiratory infections, and more by phone or video conveniently in the comfort of your home.
Analysts have upped their earnings outlook across several timeframes over the last several months. TDOC carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
TDOC’s valuation multiples have fallen significantly amid the adverse price action of shares.
Currently, the company carries a 2.1X forward price-to-sales ratio, a fraction of its 9.8X five-year median and representing a slight 1% premium relative to its Zacks Medical Sector.
Image Source: Zacks Investment Research
The company’s quarterly reports have been strong as of late – TDOC has exceeded earnings estimates in each of its last four quarters.
Quarterly revenue has also consistently come in above expectations, with the company penciling in nine top line beats over its last ten quarters.
TDOC has a very favorable revenue trend, as we can see in the chart below that illustrates the company’s revenue on a quarterly basis.
Image Source: Zacks Investment Research
Zoom Video Communications
Zoom Video Communications (ZM - Free Report) utilizes a cloud-native unified communications platform, which combines video, audio, phone, screen sharing, and chat functionalities, making remote-working and collaboration easy.
Analysts have been overwhelmingly bearish over the last several months, slashing their earnings outlook across the board. ZM carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
ZM’s valuation levels have fallen extensively but remain elevated – the company’s 5.4X forward price-to-sales ratio is nowhere near its median of 30.9X since its 2019 IPO but represents a steep 62% premium relative to its Zacks Sector.
Image Source: Zacks Investment Research
However, ZM has an impressive earnings track record – the company has exceeded the Zacks Consensus EPS Estimate in each of its last ten quarters.
Top-line results have also been strong; Zoom Video Communications has penciled in nine revenue beats over its last ten quarters.
Image Source: Zacks Investment Research
Peloton Interactive
Peloton’s (PTON - Free Report) primary products are internet-connected stationary bicycles and treadmills, enabling monthly subscribers to participate in classes via streaming media remotely.
Analysts have dialed back their earnings outlook across nearly all timeframes over the last 60 days. PTON carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
PTON’s valuation multiples have fallen extensively amid the stretch of poor price action; the company’s 1.1X forward price-to-sales ratio is nowhere near its median of 5.9X since its September 2019 IPO and represents a notable 41% discount relative to its Zacks Consumer Discretionary Sector.
Image Source: Zacks Investment Research
As of late, the company’s quarterly reports have left much to be desired – PTON has missed revenue and earnings estimates in each of its previous three quarters. Just in its latest quarter, Teladoc penciled in a wide 85% bottom line miss and a marginal 0.7% revenue miss.
Image Source: Zacks Investment Research
Bottom Line
Once seemingly unstoppable investments, the tide has shifted significantly for the pandemic winners in 2022 amid a Fed pivot to a hawkish nature.
Analysts have dialed back their earnings estimates, and shares have tumbled. However, valuation multiples have fallen significantly, perhaps indicating that long-term investors could consider getting interested.
However, a much better strategy would be for investors to wait until positive earnings estimate revisions start coming in.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Time for Investors To Revisit the Pandemic Winners?
A handful of stocks benefited massively during the initial phases of the pandemic. It was a fascinating time to be an investor, and those who targeted the stay-at-home stocks were rewarded handsomely with considerable gains.
In 2022, these once seemingly unstoppable investments have found themselves deep in the red, leaving dents in many portfolios. The Fed's tightening cycle has massively affected many of these high-growth pandemic winners.
Three stocks that gained widespread popularity during the period include Teladoc (TDOC - Free Report) , Zoom Video Communications (ZM - Free Report) , and Peloton Interactive (PTON - Free Report) .
Below is a YTD chart depicting the share performance of all three companies with the S&P 500 blended in as a benchmark.
Image Source: Zacks Investment Research
It raises a valid question, are these one-time massive winners still worth investors’ attention? Let’s take a closer look.
Teladoc
Teladoc Health (TDOC - Free Report) can diagnose and treat most non-emergency conditions such as flu, seasonal allergies, upper respiratory infections, and more by phone or video conveniently in the comfort of your home.
Analysts have upped their earnings outlook across several timeframes over the last several months. TDOC carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
TDOC’s valuation multiples have fallen significantly amid the adverse price action of shares.
Currently, the company carries a 2.1X forward price-to-sales ratio, a fraction of its 9.8X five-year median and representing a slight 1% premium relative to its Zacks Medical Sector.
Image Source: Zacks Investment Research
The company’s quarterly reports have been strong as of late – TDOC has exceeded earnings estimates in each of its last four quarters.
Quarterly revenue has also consistently come in above expectations, with the company penciling in nine top line beats over its last ten quarters.
TDOC has a very favorable revenue trend, as we can see in the chart below that illustrates the company’s revenue on a quarterly basis.
Image Source: Zacks Investment Research
Zoom Video Communications
Zoom Video Communications (ZM - Free Report) utilizes a cloud-native unified communications platform, which combines video, audio, phone, screen sharing, and chat functionalities, making remote-working and collaboration easy.
Analysts have been overwhelmingly bearish over the last several months, slashing their earnings outlook across the board. ZM carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
ZM’s valuation levels have fallen extensively but remain elevated – the company’s 5.4X forward price-to-sales ratio is nowhere near its median of 30.9X since its 2019 IPO but represents a steep 62% premium relative to its Zacks Sector.
Image Source: Zacks Investment Research
However, ZM has an impressive earnings track record – the company has exceeded the Zacks Consensus EPS Estimate in each of its last ten quarters.
Top-line results have also been strong; Zoom Video Communications has penciled in nine revenue beats over its last ten quarters.
Image Source: Zacks Investment Research
Peloton Interactive
Peloton’s (PTON - Free Report) primary products are internet-connected stationary bicycles and treadmills, enabling monthly subscribers to participate in classes via streaming media remotely.
Analysts have dialed back their earnings outlook across nearly all timeframes over the last 60 days. PTON carries a Zacks Rank #3 (Hold).
Image Source: Zacks Investment Research
PTON’s valuation multiples have fallen extensively amid the stretch of poor price action; the company’s 1.1X forward price-to-sales ratio is nowhere near its median of 5.9X since its September 2019 IPO and represents a notable 41% discount relative to its Zacks Consumer Discretionary Sector.
Image Source: Zacks Investment Research
As of late, the company’s quarterly reports have left much to be desired – PTON has missed revenue and earnings estimates in each of its previous three quarters. Just in its latest quarter, Teladoc penciled in a wide 85% bottom line miss and a marginal 0.7% revenue miss.
Image Source: Zacks Investment Research
Bottom Line
Once seemingly unstoppable investments, the tide has shifted significantly for the pandemic winners in 2022 amid a Fed pivot to a hawkish nature.
Analysts have dialed back their earnings estimates, and shares have tumbled. However, valuation multiples have fallen significantly, perhaps indicating that long-term investors could consider getting interested.
However, a much better strategy would be for investors to wait until positive earnings estimate revisions start coming in.